Leishmania donovani: Cellular and humoral immune responses in Indian langur monkeys, Presbytis entellus

Acta Tropica

Volumn 73, Issue 1, 1999, Pages 37-48

  Dube, Anuradha ^a   Srivastava, J K ^a   Sharma, P ^a   Chaturvedi, A ^a   Katiyar, J C ^a   Naik, S ^b  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Enzyme linked immunosorbent assay; Langur monkeys; Leishmania donovani; Lymphocyte proliferation assay; Presbytis entellus

Indexed keywords

CONCANAVALIN A; IMMUNOGLOBULIN G; MITOGENIC AGENT; PARASITE ANTIGEN; PHYTOHEMAGGLUTININ;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; HUMORAL IMMUNITY; LEISHMANIA DONOVANI; MALE; MONKEY; NONHUMAN; PROMASTIGOTE; T LYMPHOCYTE; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIBODIES, PROTOZOAN; CERCOPITHECIDAE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LYMPHOCYTE ACTIVATION; MALE; T-LYMPHOCYTES;

LEISHMANIA DONOVANI; PRESBYTIS ENTELLUS;

EID: 0033602826     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(99)00007-8     Document Type: Article

References (23)

1. Anuradha P.R., Guru P.Y., Katiyar J.C., Sethi N. Successful transmission of Leishmania donovani in langurs (Presbytis entellus). Curr. Sci. 59(12):1990;612-615.
2. Anuradha P.R., Zehra K., Katiyar J.C., Sethi N., Bhatia G., Singh R.K. The Indian langur: preliminary report of a new non-human primate host for visceral leishmaniasis. Bull. WHO. 70:1992;63-72.
3. Ashford R.W., Desjeux P., deRaadt P. Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitol. Today. 8:1992;104-105.
4. Binhazim A.A., Shin S.S., Chapman W.L. Jr., Olobo J.O. Comparative susceptibilty of African green monkeys (Cercopithecus aethiops) to experimental infection with L. donovani and L. donovani infantum. Lab. Anim. Sci. 43:1993;37-47.
5. Boyum A. A one stage procedure for isolation of granulocytes and lymphocytes from human blood. Scand. J. Immunol. 21:1968;31-50.
6. Bretscher P.A., Wei G., Menon J.N., Bielefeldt-Ohmann H. Establishment of stable cell mediated immunity makes `susceptible' mice resistant to Leishmania major. Science. 257:1992;539-542.
7. Curry A.J., Jardim A., Olobo J.O., Olafson R.M. Cell mediated responses of immunized vervet monkeys to defined Leishmania T cell epitopes. Infect. Immunol. 62:1994;1733-1741.
8. Dennis V.A., Lujan R., Chapman W.L., Hanson W.L. Leishmania donovani: cellular and humoral immune responses after primary and challenge infections in squirrel monkeys Saimiri sciureus. Exp. Parasitol. 61:1986;319-334.
9. Engvall E., Perlmann P. Enzyme linked immunosorbent assay (ELISA). Quantitation of specific antibodies by enzyme labelled anti-immunoglobulin in antigen coated tubes. J. Immunol. 109:1972;129-135.
10. Gicheru M.M., Olobo J.O., Kariuki T.M., Adhiambo G. Visceral leishmaniasis in vervet monkeys: Immunological responses during asymptomatic infections. Scand. J. Immunol. 41:1985;202-208.
11. Githure J.I., Shatry A.M., Tarara R., Chulay J.D., Suleman M.A., Chunge C.N., Else J.G. The suitability of East African primates as animal models of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 80:1986;575-576.
12. Hommel M., Jaffe C.L., Travei B., Milon G. Experimental models for leishmaniasis and for testing anti- leishmanial vaccines. Ann. Trop. Med. Parasitol. 89:1995;55-73.
13. Howard J.G., Liew F.Y., Hale C., Nicklin S. Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal L. tropica infection induced by irradiated promastigotes. J. Immunol. 41:1984;202-208.
14. Kaye P.M., Curry A.J., Blakcwell J.M. Differential production of TH1 and TH2 derived cytokines does notdetermine the genetically controlled or vaccine induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146:1991;2763-2770.
15. Liew F.Y. Regulation of cell mediated immunity in leishmaniasis. Curr. Trop. Microbiol. Immunol. 55:1990;53-64.
16. Lowry O.H., Rosebrough N.J., Farr A.L., Randal R.J. Protein measurement with the folin fenol reagent. J. Biol. Chem. 193:1951;245-275.
17. Neal R.A., Croft S.L. An in vitro system for determining the activity of compounds against the intracellular amastigote form of L. donovani. J. Antimicrob. Chemther. 14:1984;463-475.
18. Nickol A.D., Bonventre P.F. Immunosuppression associated with visceral leishmaniasis of hamsters. Parasite Immunol. 7:1985;439-449.
19. Olobo J.O., Handman E., Curtis J.M., Mitchell G.F. Antibodies to promastigotes during infection in mice of various phenotypes. Austr. J. Expl. Bio. Med. Sci. 58:1980;595-601.
20. Olobo J.O., Reid G.D.F., Gaithure J.I., Anjili C.O. IFN- and delayed type hypersensitivity are associated with cutaneous leishmaniasis in vervet monkeys following secondary rechallenge with Leishmania major. Scand. J. Immunol. 36:1992;48-52.
21. Rezai H.R., Ardehali S.M., Almirhakimi G., Kharuzmi A. Immunological features of kala-azar. Am. J. Trop. Med. Hyg. 27:1978;1079-1083.
22. Sacks D.L., Scott P.A., Asofsky R.A., Sher F.A. Cutaneous leishmaniasis in anti-IgM treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. J. Immunol. 34:1984;2072-2077.
23. Turk J.L., Bryceson A.D.M. Immunological phenomena in leprosy and related diseases. Adv. Immunol. 13:1971;209-266.